InterCure

InterCure Stock-Based Compensation

The Stock-Based Compensation (SBC) of InterCure (INCR.TA) as of Oct 22, 2026 is 2.57 M ILS. In the previous year, Stock-Based Compensation (SBC) was 3.02 M ILS — a change of -14.99% (lower).

Stock-Based Compensation

2.57 MILS

YoY

-14.99%

Last updated:

Stock-Based Compensation (SBC) of InterCure is 2024 2.57 M ILS. Stock-Based Compensation (SBC) of InterCure was 2023 3.02 M ILS. It decreases by -14.99% lower compared to the previous year.

The InterCure Stock-Based Compensation history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Stock-Based Compensation
Date
Stock-Based Compensation
Jan 1, 2018
7.83 M ILS
Jan 1, 2019
136.41 M ILS
Jan 1, 2020
10.01 M ILS
Jan 1, 2021
7.02 M ILS
Jan 1, 2022
9.73 M ILS
Jan 1, 2023
3.02 M ILS
Jan 1, 2024
2.57 M ILS
The InterCure Stock-Based Compensation history
YEARStock-Based CompensationYoY
2.57 MILS-14.99%
3.02 MILS-68.92%
9.73 MILS+38.60%
7.02 MILS-29.87%
10.01 MILS-92.66%
136.41 MILS+1,642.39%
7.83 MILS—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

InterCure Stock analysis

What does InterCure do? InterCure Ltd. is a global company in the medical technology industry that focuses on the development, production, and distribution of innovative solutions for the diagnosis and treatment of chronic diseases. The company was founded in Israel in 2000 and is headquartered in Lod. InterCure is one of the most popular companies on Eulerpool.

Frequently Asked Questions about InterCure stock

Stock-Based Compensation (SBC) of InterCure is 2.57 M ILS in 2024.

Stock-Based Compensation (SBC) of InterCure changed from 3.02 M ILS to 2.57 M ILS, representing a -14.99% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Stock-Based Compensation (SBC) InterCure since 2006 – with annual values, charts, and detailed analysis.

Stock-based compensation is a non-cash expense representing equity awards to employees. High SBC can dilute existing shareholders and inflate reported cash flow.

Stock-Based Compensation (SBC)'s ILS is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Stock-Based Compensation (SBC)'s InterCure historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — InterCure

All Key Metrics — InterCure